University of Veterinary and Animal Sciences, Lahore Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3

Organization Overview

First Clinical Trial
2019
NCT03894449
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Sohaib Ashraf | University of Veterinary and Animal Sciences | University of Veterinary and Animal Sciences, Lahore | University of Veterinary and Animal Sciences, Lahore - Pakistan | University Of Veterinary & Animal Sciences, Lahore | University of Veterinary & Animal Sciences, Lahore, Pakistan | University of Veterinary & Animal Sciences, Pakistan

Active Ingredients

Drugs in Phase 3 Trials (2)

honey (2 trials)

nigella sativa (3 trials)

Drugs in Phase 2 Trials (7)

alpha-galacto-oligosaccharides (1 trial)

alprazolam (xanax) (1 trial)

inulin (1 trial)

iodine (1 trial)

iron sulfate (1 trial)

ivermectin (stromectol) (1 trial)

zinc (1 trial)

Drugs in Phase 1 Trials (2)

barley (1 trial)

wheat flour (1 trial)

Drugs in Other Trials (1)

fenugreek seed (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Iron-Deficiency (Phase 2)

Coronavirus Infections (Phase 3)

Infections (Phase 3)

Severe Acute Respiratory Syndrome (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 12